NTRA
Natera, Inc.
Company overview
- Market capitalization
- $59.35B
- Employees
- 6,135
- Latest publication
- 2026-09-29
About Natera, Inc.
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in Januar
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20142014-12-31 · USD | Q3 20142014-09-30 · USD | Q2 20132013-06-30 · USD |
|---|---|---|---|---|
| Total Revenue | 752,750,000USD | 49,884,000USD | 46,274,000USD | 11,063,000USD |
| Cost Of Revenue | 533,194,000USD | 22,662,000USD | 20,820,000USD | 8,941,000USD |
| Gross Profit | 219,556,000USD | 27,222,000USD | 25,454,000USD | 0USD |
| Research Development | 228,071,000USD | 4,500,000USD | 4,372,000USD | 2,574,000USD |
| Selling General Administrative | 327,203,000USD | 17,249,000USD | 20,675,000USD | 9,492,000USD |
| Total Operating Expenses | 295,348,000USD | 22,849,000USD | 20,675,000USD | 0USD |
| Operating Income | -75,792,000USD | 4,373,000USD | 4,779,000USD | 0USD |
| Total Other Income Expense Net | 8,562,000USD | -3,119,000USD | -1,055,000USD | 0USD |
| Interest Expense | 890,000USD | 2,396,000USD | 1,202,000USD | 447,000USD |
| Income Before Tax | -67,230,000USD | 1,254,000USD | 3,724,000USD | 0USD |
| Income Tax Expense | -261,000USD | 549,000USD | 641,000USD | 0USD |
| Net Income | -66,969,000USD | 1,254,000USD | 3,724,000USD | 0USD |
| Selling And Marketing Expenses | — | 1,100,000USD | — | — |
| Net Income From Continuing Ops | — | -5,152,000USD | 0USD | 0USD |
| Ebit | — | 4,373,000USD | 4,779,000USD | 0USD |
| Ebitda | — | 5,851,000USD | 6,141,000USD | — |
| Depreciation And Amortization | — | 1,478,000USD | 1,362,000USD | — |
| Reconciled Depreciation | — | 1,478,000USD | 1,362,000USD | — |
| Minority Interest | — | 0USD | 0USD | 0USD |
| Discontinued Operations | — | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | 1,254,000USD | 3,724,000USD | 0USD |
| Unclassified Operating Expenses | — | — | -4,372,000USD | -12,066,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,657,497,000USD | 2,614,398,000USD | 2,508,037,000USD | 1,821,482,000USD | 1,757,066,000USD | 1,732,366,000USD | 1,660,735,000USD | 1,590,947,000USD |
| Total Current Assets | 1,658,950,000USD | 1,651,813,000USD | 1,496,939,000USD | 1,447,323,000USD | 1,431,596,000USD | 1,416,385,000USD | 1,375,820,000USD | 1,322,565,000USD |
| Other Current Assets | 65,134,000USD | 75,565,000USD | 55,828,000USD | 53,861,999USD | 52,104,000USD | 56,185,000USD | 48,635,000USD | 44,631,000USD |
| Other Non Current Assets | 49,988,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 835,998,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 553,200,000USD | 558,257,000USD | 441,228,000USD | 442,016,000USD | 384,836,000USD | 365,677,000USD | 344,045,000USD | 301,416,000USD |
| Other Current Liabilities | 228,456,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 25,262,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,821,499,000USD | 1,774,018,000USD | 1,712,413,000USD | 1,252,188,000USD | 1,246,182,000USD | 1,239,675,000USD | 1,195,420,000USD | 878,525,000USD |
| Total Equity Including Noncontrolling Interest | 1,821,499,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 40,566,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 16,074,000USD | — | — | — | — | — | — | — |
| Net Receivables | 421,968,000USD | 417,595,000USD | 296,528,000USD | 286,379,000USD | 309,224,000USD | 318,233,000USD | 314,165,000USD | 306,876,000USD |
| Inventory | 80,346,000USD | 70,721,000USD | 68,443,000USD | 64,644,000USD | 54,272,000USD | 50,367,000USD | 44,744,000USD | 48,724,000USD |
| Property Plant Equipment Net | 447,255,000USD | 403,366,000USD | 349,725,000USD | 303,484,000USD | 284,352,000USD | 275,084,000USD | 248,195,000USD | 230,026,000USD |
| Goodwill | 141,100,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 360,204,000USD | 367,362,000USD | 373,713,000USD | — | — | — | 10,933,000USD | — |
| Accounts Payable | 75,154,000USD | 62,397,000USD | 33,156,000USD | 46,499,000USD | 36,879,000USD | 39,240,000USD | 34,922,000USD | 27,834,000USD |
| Short Term Debt | 15,123,000USD | 95,128,000USD | 95,904,000USD | 94,347,000USD | 93,394,000USD | 92,544,000USD | 90,530,000USD | 90,231,000USD |
| Common Stock | 14,000USD | 14,000USD | 14,000USD | 14,000USD | 14,000USD | 14,000USD | 12,000USD | 12,000USD |
| Retained Earnings | -2,928,082,000USD | -2,861,113,000USD | -2,776,022,000USD | -2,823,280,000USD | -2,735,736,000USD | -2,634,798,000USD | -2,567,862,000USD | -2,514,091,000USD |
| Accumulated Other Comprehensive Income | -108,000USD | -202,000USD | -258,000USD | -186,999USD | -287,000USD | -197,000USD | -344,000USD | -765,000USD |
| Cash And Equivalents | 1,091,502,000USD | — | — | — | — | — | — | — |
| Total Liab | — | 840,380,000USD | 795,624,000USD | 569,294,000USD | 510,884,000USD | 492,691,000USD | 465,315,000USD | 712,422,000USD |
| Other Current Liab | — | 363,880,000USD | 287,261,000USD | 279,384,000USD | 226,468,000USD | 213,336,000USD | 194,423,000USD | 160,404,000USD |
| Capital Stock | — | 14,000USD | 14,000USD | 14,000USD | 14,000USD | 14,000USD | 12,000USD | 12,000USD |
| Good Will | — | 140,857,000USD | 141,070,000USD | — | — | — | 0USD | — |
| Cash | — | 1,087,932,000USD | 1,076,140,000USD | 1,041,438,000USD | 1,000,021,000USD | 973,768,000USD | 945,587,000USD | 892,844,000USD |
| Cash And Short Term Investments | — | 1,087,932,000USD | 1,076,140,000USD | 1,042,438,000USD | 1,015,996,000USD | 991,600,000USD | 968,276,000USD | 922,334,000USD |
| Current Deferred Revenue | — | 36,852,000USD | 24,907,000USD | 21,786,000USD | 21,560,000USD | 20,557,000USD | 19,754,000USD | 17,886,000USD |
| Net Debt | — | -847,851,000USD | -861,763,000USD | -842,711,000USD | -803,886,000USD | -778,168,000USD | -758,469,000USD | -417,111,000USD |
| Short Long Term Debt | — | 80,305,000USD | 80,323,000USD | 80,341,000USD | 80,338,000USD | 80,345,000USD | 80,362,000USD | 80,469,000USD |
| Short Long Term Debt Total | — | 240,081,000USD | 214,377,000USD | 198,727,000USD | 196,135,000USD | 195,600,000USD | 187,118,000USD | 475,733,000USD |
| Property Plant Equipment Gross | — | 523,778,000USD | 460,803,000USD | 404,374,000USD | 376,003,000USD | 361,664,000USD | 326,611,000USD | 301,154,000USD |
| Common Stock Shares Outstanding | — | 141,502,000shares | 136,721,000shares | 137,187,000shares | 136,388,000shares | 134,750,000shares | 124,718,000shares | 123,775,000shares |
| Non Current Assets Total | — | 962,585,000USD | 1,011,097,999USD | 374,159,000USD | 325,470,000USD | 315,981,000USD | 284,915,000USD | 268,382,000USD |
| Non Current Liabilities Total | — | 282,123,000USD | 354,396,000USD | 127,278,000USD | 126,048,000USD | 127,014,000USD | 121,270,000USD | 411,006,000USD |
| Non Current Liabilities Other | — | 16,266,000USD | 11,687,000USD | — | — | — | 7,844,000USD | — |
| Non Currrent Assets Other | — | 51,000,000USD | 36,896,999USD | 70,675,000USD | 41,118,000USD | 40,897,000USD | 36,720,000USD | 38,356,000USD |
| Net Working Capital | — | 1,093,556,000USD | 1,055,711,000USD | 1,005,307,000USD | 1,046,760,000USD | 1,050,708,000USD | 1,031,775,000USD | 1,021,149,000USD |
| Unclassified Current Liabilities | — | -80,305,000USD | -80,323,000USD | -80,341,000USD | -73,803,000USD | -80,345,000USD | -75,946,000USD | -75,408,000USD |
| Unclassified Non Current Liabilities | — | 265,857,000USD | 342,709,000USD | 127,278,000USD | 126,048,000USD | 127,014,000USD | 113,426,000USD | 124,457,000USD |
| Unclassified Equity | — | 4,635,305,000USD | 4,488,665,000USD | 4,075,626,999USD | 3,982,177,000USD | 3,874,642,000USD | 3,763,602,000USD | 3,393,357,000USD |
| Short Term Investments | — | — | 0USD | 1,000,000USD | 15,975,000USD | 17,832,000USD | 22,689,000USD | 29,490,000USD |
| Unclassified Non Current Assets | — | — | 109,693,000USD | — | — | — | -10,933,000USD | — |
| Long Term Debt | — | — | — | — | — | — | — | 286,549,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,508,037,000USD | 1,660,735,000USD | 1,441,699,000USD | 1,394,474,000USD | 1,236,487,000USD | 932,153,000USD | 582,656,000USD | 268,171,000USD |
| Intangible Assets | 373,713,000USD | 10,933,000USD | — | — | 2,300,000USD | 1,700,000USD | 1,200,000USD | 1,700,000USD |
| Other Current Assets | 55,828,000USD | 48,635,000USD | 60,524,000USD | 33,634,000USD | 29,873,000USD | 26,793,000USD | 16,431,000USD | 10,794,000USD |
| Total Liab | 795,624,000USD | 465,315,000USD | 676,372,000USD | 688,730,000USD | 583,183,000USD | 445,917,000USD | 303,945,000USD | 236,009,000USD |
| Total Stockholder Equity | 1,712,413,000USD | 1,195,420,000USD | 765,327,000USD | 705,744,000USD | 653,304,000USD | 486,236,000USD | 278,711,000USD | 32,162,000USD |
| Other Current Liab | 287,261,000USD | 194,423,000USD | 179,910,000USD | 176,266,000USD | 126,312,000USD | 81,755,000USD | 57,701,000USD | 43,855,000USD |
| Common Stock | 14,000USD | 12,000USD | 11,000USD | 11,000USD | 10,000USD | 9,000USD | 8,000USD | 7,000USD |
| Capital Stock | 14,000USD | 12,000USD | 11,000USD | 11,000USD | 10,000USD | 9,000USD | 8,000USD | 7,000USD |
| Retained Earnings | -2,776,022,000USD | -2,567,862,000USD | -2,377,436,000USD | -1,942,635,000USD | -1,394,836,000USD | -929,318,000USD | -699,171,000USD | -574,529,000USD |
| Good Will | 141,070,000USD | 0USD | — | — | — | — | — | — |
| Cash | 1,076,140,000USD | 945,587,000USD | 642,095,000USD | 466,091,000USD | 84,386,000USD | 48,668,000USD | 61,926,000USD | 46,407,000USD |
| Cash And Short Term Investments | 1,076,140,000USD | 968,276,000USD | 878,977,000USD | 898,392,000USD | 914,282,000USD | 737,274,000USD | 440,991,000USD | 153,868,000USD |
| Total Current Assets | 1,496,939,000USD | 1,375,820,000USD | 1,258,549,000USD | 1,211,817,000USD | 1,093,138,000USD | 862,663,000USD | 523,167,000USD | 240,518,000USD |
| Total Current Liabilities | 441,228,000USD | 344,045,000USD | 307,274,000USD | 310,499,000USD | 218,956,000USD | 199,053,000USD | 179,874,000USD | 113,981,000USD |
| Current Deferred Revenue | 24,907,000USD | 19,754,000USD | 16,612,000USD | 10,777,000USD | 7,404,000USD | 50,125,000USD | 56,016,000USD | 4,131,000USD |
| Net Debt | -861,763,000USD | -758,469,000USD | -200,102,000USD | -19,872,000USD | 312,848,000USD | 232,425,000USD | 93,889,000USD | 77,103,000USD |
| Short Term Debt | 95,904,000USD | 90,530,000USD | 92,023,000USD | 87,989,000USD | 55,804,000USD | 57,354,000USD | 55,862,000USD | 50,153,000USD |
| Short Long Term Debt | 80,323,000USD | 80,362,000USD | 80,402,000USD | 80,350,000USD | 50,052,000USD | 50,054,000USD | 50,123,000USD | 50,153,000USD |
| Short Long Term Debt Total | 214,377,000USD | 187,118,000USD | 441,993,000USD | 446,219,000USD | 397,234,000USD | 281,093,000USD | 155,815,000USD | 123,510,000USD |
| Short Term Investments | 0USD | 22,689,000USD | 236,882,000USD | 432,301,000USD | 829,896,000USD | 688,606,000USD | 379,065,000USD | 107,461,000USD |
| Net Receivables | 296,528,000USD | 314,165,000USD | 278,289,000USD | 244,385,000USD | 122,074,000USD | 78,565,000USD | 53,351,000USD | 62,223,000USD |
| Inventory | 68,443,000USD | 44,744,000USD | 40,759,000USD | 35,406,000USD | 26,909,000USD | 20,031,000USD | 12,394,000USD | 13,633,000USD |
| Accounts Payable | 33,156,000USD | 34,922,000USD | 14,998,000USD | 31,148,000USD | 27,206,000USD | 8,096,000USD | 8,604,000USD | 14,587,000USD |
| Property Plant Equipment Net | 349,725,000USD | 248,195,000USD | 167,747,000USD | 164,327,000USD | 124,529,000USD | 54,747,000USD | 47,013,000USD | 24,336,000USD |
| Property Plant Equipment Gross | 460,803,000USD | 326,611,000USD | 224,040,000USD | 164,327,000USD | 124,529,000USD | 54,747,000USD | 47,013,000USD | 24,336,000USD |
| Accumulated Other Comprehensive Income | -258,000USD | -344,000USD | -3,085,000USD | -16,362,000USD | -2,287,000USD | 4,259,000USD | 919,000USD | -552,000USD |
| Common Stock Shares Outstanding | 136,721,000shares | 124,718,000shares | 114,997,000shares | 98,408,000shares | 90,558,000shares | 81,011,000shares | 69,555,000shares | 57,848,000shares |
| Non Current Assets Total | 1,011,097,999USD | 284,915,000USD | 183,150,000USD | 182,657,000USD | 143,349,000USD | 69,490,000USD | 59,489,000USD | 27,653,000USD |
| Non Current Liabilities Total | 354,396,000USD | 121,270,000USD | 369,098,000USD | 378,231,000USD | 364,227,000USD | 246,864,000USD | 124,071,000USD | 122,028,000USD |
| Non Current Liabilities Other | 11,687,000USD | 7,844,000USD | — | 96,578,000USD | 83,833,000USD | 44,371,000USD | 50,415,000USD | 48,671,000USD |
| Non Currrent Assets Other | 36,896,999USD | 36,720,000USD | 15,403,000USD | 18,330,000USD | 18,820,000USD | 14,743,000USD | 12,476,000USD | 3,317,000USD |
| Net Working Capital | 1,055,711,000USD | 1,031,775,000USD | 951,275,000USD | 901,318,000USD | 874,182,000USD | 663,610,000USD | 343,293,000USD | 126,537,000USD |
| Unclassified Non Current Assets | 109,693,000USD | -10,933,000USD | — | -18,330,000USD | -21,120,000USD | -37,842,000USD | -13,676,000USD | -5,017,000USD |
| Unclassified Current Liabilities | -80,323,000USD | -75,946,000USD | -76,671,000USD | -76,031,000USD | -47,822,000USD | -48,331,000USD | -48,432,000USD | -48,898,000USD |
| Unclassified Non Current Liabilities | 342,709,000USD | 113,426,000USD | 86,153,000USD | -20,001,000USD | -22,797,000USD | -23,125,000USD | -25,218,000USD | -48,771,000USD |
| Unclassified Equity | 4,488,665,000USD | 3,763,602,000USD | 3,145,826,000USD | 2,664,719,000USD | 2,050,407,000USD | 1,411,277,000USD | 976,947,000USD | 607,229,000USD |
| Long Term Debt | — | — | 282,945,000USD | 281,653,000USD | 280,394,000USD | 202,493,000USD | 73,656,000USD | 73,357,000USD |
| Other Liab | — | — | — | 20,001,000USD | 22,797,000USD | 23,125,000USD | 24,118,000USD | 48,671,000USD |
| Other Assets | — | — | — | 18,330,000USD | 18,820,000USD | 36,142,000USD | 12,476,000USD | 3,317,000USD |
| Net Tangible Assets | — | — | — | 705,744,000USD | 653,304,000USD | 486,236,000USD | 278,711,000USD | 32,162,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | 1,100,000USD | 100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 29,998,000USD |
| Stock Based Compensation | 198,204,000USD |
| Other Non Cash Items | -449,000USD |
| Change To Account Receivables | -125,440,000USD |
| Change To Inventory | -11,903,000USD |
| Change To Liabilities | 34,044,000USD |
| Change In Working Capital | -52,305,000USD |
| Operating Cash Flow | 94,964,000USD |
| Capital Expenditures | -85,566,000USD |
| Net Investments | 0USD |
| Unclassified Investing Cash Flow | -10,000,000USD |
| Investing Cash Flow | -95,566,000USD |
| Common Stock Issuance | 16,430,000USD |
| Net Common Stock Issuance | -5,097,000USD |
| Unclassified Financing Cash Flow | 4,631,000USD |
| Financing Cash Flow | 15,964,000USD |
| Change In Cash | 15,362,000USD |
| End Cash Flow | 1,100,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -85,091,000USD | 47,258,000USD | -87,544,000USD | -100,938,000USD | -66,936,000USD | -53,771,000USD | -31,592,000USD | -37,464,000USD |
| Depreciation | 20,226,000USD | 14,096,000USD | 10,292,000USD | 9,859,000USD | 9,237,000USD | 7,790,000USD | 8,200,000USD | 7,915,000USD |
| Stock Based Compensation | 95,107,000USD | 92,582,000USD | 90,637,000USD | 93,358,000USD | 77,827,000USD | 71,926,000USD | 70,644,000USD | 67,411,000USD |
| Other Non Cash Items | 12,755,000USD | 97,617,000USD | 5,075,000USD | 4,495,000USD | 923,000USD | 4,070,000USD | 6,813,000USD | 3,851,000USD |
| Change To Account Receivables | -121,067,000USD | -7,034,000USD | 22,845,000USD | 9,009,000USD | -4,068,000USD | -7,289,000USD | 29,060,000USD | -47,188,000USD |
| Change To Inventory | -2,278,000USD | -971,000USD | -10,372,000USD | -3,905,000USD | -5,623,000USD | 3,980,000USD | -7,740,000USD | 2,040,000USD |
| Change In Working Capital | -2,826,000USD | -24,283,000USD | 40,927,000USD | 30,800,000USD | 23,401,000USD | 22,872,000USD | -2,279,000USD | -37,723,000USD |
| Total Cash From Operating Activities | 40,171,000USD | 73,888,000USD | 59,387,000USD | 37,574,000USD | 44,452,000USD | 52,887,000USD | 51,786,000USD | 3,990,000USD |
| Capital Expenditures | -22,137,000USD | -36,071,000USD | -34,905,000USD | -25,897,000USD | -21,815,000USD | -18,118,000USD | -16,312,000USD | -11,678,000USD |
| Free Cash Flow | 18,034,000USD | 37,817,000USD | 24,482,000USD | 11,677,000USD | 22,637,000USD | 34,769,000USD | 35,474,000USD | -7,688,000USD |
| Investments | -10,000,000USD | 1,000,000USD | -19,905,000USD | -23,897,000USD | -16,815,000USD | -11,118,000USD | 42,540,000USD | -32,053,000USD |
| Total Cashflows From Investing Activities | -32,137,000USD | -71,592,000USD | -19,905,000USD | -23,897,000USD | -16,815,000USD | -11,118,000USD | 42,540,000USD | -32,053,000USD |
| Total Cash From Financing Activities | 3,758,000USD | 32,406,000USD | 1,935,000USD | 12,576,000USD | 544,000USD | 10,974,000USD | 1,720,000USD | 11,044,000USD |
| Change In Cash | 11,792,000USD | 34,702,000USD | 41,417,000USD | 26,253,000USD | 28,181,000USD | 52,743,000USD | 96,046,000USD | -17,019,000USD |
| Begin Period Cash Flow | 1,076,140,000USD | 1,041,438,000USD | 1,000,021,000USD | 973,768,000USD | 945,587,000USD | 892,844,000USD | 796,798,000USD | 813,817,000USD |
| End Period Cash Flow | 1,087,932,000USD | 1,076,140,000USD | 1,041,438,000USD | 1,000,021,000USD | 973,768,000USD | 945,587,000USD | 892,844,000USD | 796,798,000USD |
| Other Cashflows From Investing Activities | — | -15,021,000USD | -12,500,000USD | -10,000USD | -9,000USD | — | 60,278,000USD | -72,810,000USD |
| Unclassified Operating Cash Flow | — | -153,382,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | -21,500,000USD | 47,405,000USD | 25,907,000USD | 21,824,000USD | 18,118,000USD | -43,966,000USD | 84,488,000USD |
| Other Cashflows From Financing Activities | — | — | 1,935,000USD | — | -31,519,000USD | 10,974,000USD | 1,720,000USD | 11,044,000USD |
| Sale Purchase Of Stock | — | — | — | 12,236,000USD | — | — | 8,862,000USD | — |
| Unclassified Financing Cash Flow | — | — | — | — | 32,063,000USD | — | -8,862,000USD | — |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -208,160,000USD | -190,426,000USD | -434,801,000USD | -547,799,000USD | -471,716,000USD | -229,743,000USD | -124,827,000USD | -128,154,000USD |
| Depreciation | 43,484,000USD | 30,968,000USD | 24,097,000USD | 16,702,000USD | 11,254,000USD | 8,613,000USD | 7,730,000USD | 7,501,000USD |
| Stock Based Compensation | 354,404,000USD | 274,428,000USD | 191,808,000USD | 152,384,000USD | 115,219,000USD | 50,171,000USD | 28,624,000USD | 14,198,000USD |
| Other Non Cash Items | 369,932,000USD | 18,553,000USD | 19,894,000USD | 30,362,000USD | 55,608,000USD | 14,719,000USD | -2,172,000USD | 8,718,000USD |
| Change To Account Receivables | 20,752,000USD | -35,876,000USD | -33,904,000USD | -122,311,000USD | -43,509,000USD | -25,831,000USD | 2,418,000USD | -18,093,000USD |
| Change To Inventory | -20,871,000USD | -3,985,000USD | -5,353,000USD | -8,497,000USD | -6,878,000USD | -7,474,000USD | 917,000USD | -4,900,000USD |
| Change In Working Capital | 70,845,000USD | 2,141,000USD | -47,953,000USD | -83,150,000USD | -45,601,000USD | -39,130,000USD | 27,201,000USD | 27,156,000USD |
| Total Cash From Operating Activities | 215,301,000USD | 135,664,000USD | -246,955,000USD | -431,501,000USD | -335,236,000USD | -182,512,000USD | -63,444,000USD | -70,581,000USD |
| Capital Expenditures | -106,188,000USD | -66,423,000USD | -39,199,000USD | -47,697,000USD | -41,030,000USD | -19,604,000USD | -4,968,000USD | -3,880,000USD |
| Free Cash Flow | 109,113,000USD | 69,241,000USD | -286,154,000USD | -479,198,000USD | -376,266,000USD | -202,116,000USD | -68,412,000USD | -74,461,000USD |
| Investments | 23,000,000USD | 137,624,000USD | 168,498,000USD | 378,035,000USD | -155,605,000USD | -311,857,000USD | -271,060,000USD | -1,281,000USD |
| Total Cashflows From Investing Activities | -132,209,000USD | 137,624,000USD | 168,498,000USD | 330,338,000USD | -205,193,000USD | -331,461,000USD | -266,353,000USD | -5,161,000USD |
| Net Borrowings | 0USD | -82,000USD | 0USD | 30,000,000USD | 30,000,000USD | 199,559,000USD | 199,559,000USD | 199,559,000USD |
| Total Cash From Financing Activities | 47,461,000USD | 30,204,000USD | 254,461,000USD | 482,640,000USD | 576,188,000USD | 500,847,000USD | 340,774,000USD | 113,725,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 235,441,000USD | 433,192,000USD | 550,822,000USD | 270,650,000USD | 323,410,000USD | 96,777,000USD |
| Change In Cash | 130,553,000USD | 303,492,000USD | 176,004,000USD | 381,477,000USD | 35,759,000USD | -13,126,000USD | 10,977,000USD | 37,983,000USD |
| Begin Period Cash Flow | 945,587,000USD | 642,095,000USD | 466,091,000USD | 84,614,000USD | 48,855,000USD | 61,981,000USD | 51,004,000USD | 13,021,000USD |
| End Period Cash Flow | 1,076,140,000USD | 945,587,000USD | 642,095,000USD | 466,091,000USD | 84,614,000USD | 48,855,000USD | 61,981,000USD | 51,004,000USD |
| Other Cashflows From Investing Activities | 6,979,000USD | -10,495,000USD | — | 378,035,000USD | -8,558,000USD | -311,857,000USD | -261,385,000USD | -1,281,000USD |
| Unclassified Operating Cash Flow | -415,204,000USD | — | — | — | — | 12,858,000USD | — | — |
| Unclassified Investing Cash Flow | -56,000,000USD | 76,918,000USD | 39,199,000USD | -378,035,000USD | — | 311,857,000USD | 271,060,000USD | 1,281,000USD |
| Unclassified Financing Cash Flow | 47,461,000USD | -17,298,000USD | 220,313,000USD | 16,963,000USD | 507,272,000USD | -7,666,000USD | 119,528,000USD | -106,399,000USD |
| Sale Purchase Of Stock | — | 17,298,000USD | 15,128,000USD | 13,037,000USD | 13,550,000USD | 7,114,000USD | 4,323,000USD | 3,617,000USD |
| Other Cashflows From Financing Activities | — | 30,286,000USD | 19,020,000USD | 452,640,000USD | 25,366,000USD | 308,954,000USD | 17,364,000USD | 16,948,000USD |
| Change To Liabilities | — | — | — | 56,181,000USD | 62,473,000USD | 24,516,000USD | 6,073,000USD | 47,799,000USD |
| Dividends Paid | — | — | — | -30,000,000USD | — | -7,114,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | 381,477,000USD | 35,759,000USD | -13,126,000USD | 10,977,000USD | 37,983,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Americas Excluding United States | 2,220,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Asia Pacific And Other | 2,046,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | EMEA | 9,015,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 739,469,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Licensing And Other | 4,821,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 747,929,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Americas Excluding United States | 2,402,000 | USD | 0001628280-26-032478 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific And Other | 2,219,000 | USD | 0001628280-26-032478 |
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 6,425,000 | USD | 0001628280-26-032478 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 685,598,000 | USD | 0001628280-26-032478 |
| Q1 2026Quarterly · 2026-03-31 | Product | Licensing And Other | 2,776,000 | USD | 0001628280-26-032478 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 693,868,000 | USD | 0001628280-26-032478 |
| Q4 2025Quarterly · 2025-12-31 | Product | Licensing And Other | 4,340,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 661,160,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Americas Excluding Us | 9,354,000 | USD | 0001104659-26-020881 |
| FY 2025Yearly · 2025-12-31 | Geography | Europe Middle East India And Africa | 24,480,000 | USD | 0001104659-26-020881 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Geographic Areas | 8,014,000 | USD | 0001104659-26-020881 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 2,264,265,000 | USD | 0001104659-26-020881 |
| FY 2025Yearly · 2025-12-31 | Product | Licensing And Other | 10,293,000 | USD | 0001104659-26-020881 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 2,295,820,000 | USD | 0001104659-26-020881 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Americas Excluding Us | 1,523,000 | USD | 0001104659-25-107976 |
| Q3 2025Quarterly · 2025-09-30 | Geography | EMEA | 6,006,000 | USD | 0001104659-25-107976 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Other Geographic Areas | 2,283,000 | USD | 0001104659-25-107976 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 582,371,000 | USD | 0001104659-25-107976 |
| Q3 2025Quarterly · 2025-09-30 | Product | Licensing And Other | 1,986,000 | USD | 0001104659-25-107976 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 590,197,000 | USD | 0001104659-25-107976 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Americas Excluding Us | 1,571,000 | USD | 0001558370-25-010829 |
| Q2 2025Quarterly · 2025-06-30 | Geography | EMEA | 5,408,000 | USD | 0001558370-25-010829 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Other Geographic Areas | 1,820,000 | USD | 0001558370-25-010829 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 537,801,000 | USD | 0001558370-25-010829 |
| Q2 2025Quarterly · 2025-06-30 | Product | Licensing And Other | 2,173,000 | USD | 0001558370-25-010829 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 544,427,000 | USD | 0001558370-25-010829 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Americas Excluding United States | 1,692,000 | USD | 0001628280-26-032478 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia Pacific And Other | 1,784,000 | USD | 0001628280-26-032478 |
| Q1 2025Quarterly · 2025-03-31 | Geography | EMEA | 6,049,000 | USD | 0001628280-26-032478 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 492,305,000 | USD | 0001628280-26-032478 |
| Q1 2025Quarterly · 2025-03-31 | Product | Licensing And Other | 1,794,000 | USD | 0001628280-26-032478 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 500,036,000 | USD | 0001628280-26-032478 |
| Q4 2024Quarterly · 2024-12-31 | Product | Licensing And Other | 3,150,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 472,911,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Americas Excluding Us | 6,620,000 | USD | 0001104659-26-020881 |
| FY 2024Yearly · 2024-12-31 | Geography | Europe Middle East India And Africa | 23,884,000 | USD | 0001104659-26-020881 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Geographic Areas | 8,662,000 | USD | 0001104659-26-020881 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 1,657,745,000 | USD | 0001104659-26-020881 |
| FY 2024Yearly · 2024-12-31 | Product | Licensing And Other | 11,837,000 | USD | 0001104659-26-020881 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 1,685,074,000 | USD | 0001104659-26-020881 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Americas Excluding Us | 2,002,000 | USD | 0001104659-25-107976 |
| Q3 2024Quarterly · 2024-09-30 | Geography | EMEA | 7,722,000 | USD | 0001104659-25-107976 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Other Geographic Areas | 3,760,000 | USD | 0001104659-25-107976 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 426,274,000 | USD | 0001104659-25-107976 |
| Q3 2024Quarterly · 2024-09-30 | Product | Licensing And Other | 3,631,000 | USD | 0001104659-25-107976 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 436,127,000 | USD | 0001104659-25-107976 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Americas Excluding Us | 1,601,000 | USD | 0001558370-25-010829 |
| Q2 2024Quarterly · 2024-06-30 | Geography | EMEA | 5,439,000 | USD | 0001558370-25-010829 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Other Geographic Areas | 1,439,000 | USD | 0001558370-25-010829 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 404,872,000 | USD | 0001558370-25-010829 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Americas Excluding Us | 1,481,000 | USD | 0001558370-25-007036 |
| Q1 2024Quarterly · 2024-03-31 | Geography | EMEA | 5,178,000 | USD | 0001558370-25-007036 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Other Geographic Areas | 1,669,000 | USD | 0001558370-25-007036 |
| Q1 2024Quarterly · 2024-03-31 | Geography | United States | 359,413,000 | USD | 0001558370-25-007036 |
| FY 2023Yearly · 2023-12-31 | Geography | Americas Excluding Us | 4,908,000 | USD | 0001104659-26-020881 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe Middle East India And Africa | 22,811,000 | USD | 0001104659-26-020881 |
| FY 2023Yearly · 2023-12-31 | Geography | Other Geographic Areas | 7,216,000 | USD | 0001104659-26-020881 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 1,047,636,000 | USD | 0001104659-26-020881 |
| FY 2023Yearly · 2023-12-31 | Product | Licensing And Other | 14,049,000 | USD | 0001104659-26-020881 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 1,068,522,000 | USD | 0001104659-26-020881 |
| FY 2022Yearly · 2022-12-31 | Geography | Americas Excluding Us | 3,705,000 | USD | 0001558370-25-001869 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe Middle East India And Africa | 16,640,000 | USD | 0001558370-25-001869 |
| FY 2022Yearly · 2022-12-31 | Geography | Other Geographic Areas | 14,028,000 | USD | 0001558370-25-001869 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 785,849,000 | USD | 0001558370-25-001869 |
| FY 2022Yearly · 2022-12-31 | Product | Licensing And Other | 22,915,000 | USD | 0001558370-25-001869 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 797,307,000 | USD | 0001558370-25-001869 |
| FY 2021Yearly · 2021-12-31 | Geography | Americas Excluding Us | 4,047,000 | USD | 0001558370-24-002083 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe Middle East India And Africa | 20,429,000 | USD | 0001558370-24-002083 |
| FY 2021Yearly · 2021-12-31 | Geography | Other Geographic Areas | 10,138,000 | USD | 0001558370-24-002083 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 590,872,000 | USD | 0001558370-24-002083 |
| FY 2021Yearly · 2021-12-31 | Product | Licensing And Other | 45,406,000 | USD | 0001558370-24-002083 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 580,080,000 | USD | 0001558370-24-002083 |
| FY 2020Yearly · 2020-12-31 | Geography | Americas Excluding Us | 3,469,000 | USD | 0001558370-23-002460 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe Middle East India And Africa | 14,332,000 | USD | 0001558370-23-002460 |
| FY 2020Yearly · 2020-12-31 | Geography | Other Geographic Areas | 7,544,000 | USD | 0001558370-23-002460 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 365,660,000 | USD | 0001558370-23-002460 |
| FY 2020Yearly · 2020-12-31 | Product | Licensing And Other | 13,128,000 | USD | 0001558370-23-002460 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 377,877,000 | USD | 0001558370-23-002460 |
| FY 2019Yearly · 2019-12-31 | Geography | Americas Excluding Us | 3,218,000 | USD | 0001558370-22-002022 |
| FY 2019Yearly · 2019-12-31 | Geography | Europe Middle East India And Africa | 15,434,000 | USD | 0001558370-22-002022 |
| FY 2019Yearly · 2019-12-31 | Geography | Other Geographic Areas | 22,830,000 | USD | 0001558370-22-002022 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 260,846,000 | USD | 0001558370-22-002022 |
| FY 2019Yearly · 2019-12-31 | Product | Licensing And Other — License And Development Services | 16,379,000 | USD | 0001558370-20-001821 |
| FY 2019Yearly · 2019-12-31 | Product | Licensing And Other — Upfront License And Constellation And Paternity Services | 5,089,000 | USD | 0001558370-20-001821 |
| FY 2019Yearly · 2019-12-31 | Product | Other Licensing And Other | 10,979,000 | USD | 0001558370-20-001821 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 269,881,000 | USD | 0001558370-20-001821 |
| FY 2018Yearly · 2018-12-31 | Geography | Americas Excluding Us | 3,472,000 | USD | 0001558370-21-001907 |
| FY 2018Yearly · 2018-12-31 | Geography | Europe Middle East India And Africa | 20,866,000 | USD | 0001558370-21-001907 |
| FY 2018Yearly · 2018-12-31 | Geography | Other Geographic Areas | 7,385,000 | USD | 0001558370-21-001907 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 225,931,000 | USD | 0001558370-21-001907 |
| FY 2018Yearly · 2018-12-31 | Product | Hcs | 87,171,000 | USD | 0001558370-19-002131 |
| FY 2018Yearly · 2018-12-31 | Product | Licensing And Other — Constellation | 4,844,000 | USD | 0001558370-19-002131 |
| FY 2018Yearly · 2018-12-31 | Product | Licensing And Other — Qiagen | 5,794,000 | USD | 0001558370-19-002131 |
| FY 2018Yearly · 2018-12-31 | Product | Other Genetic Tests | 12,263,000 | USD | 0001558370-19-002131 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.